Circadian variation in O6-methylguanine-DNA methyltransferase activity in mouse liver

Anti-Cancer Drugs

Volumn 7, Issue 6, 1996, Pages 703-709

  Martineau Pivoteau, Nathalie ^a,b   Cussac Buchdahl, Catherine ^b   Chollet, Philippe ^b   Rolhion, Christine ^b   Debiton, Eric ^b   Rapp, Maryse ^b   Kwiatkowski, Fabrice ^b   Madelmont, Jean Claude ^b   Levi, Francis ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b CENTRE JEAN PERRIN   (France)

Author keywords

Chloroethylnitrosoureas; Circadian; Liver; Mice; O6 methylguanine DNA methyltransferase; Resistance

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; DNA METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; COMPARATIVE STUDY; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; CIRCADIAN RHYTHM; DNA MODIFICATION METHYLASES; LIVER; MALE; MICE;

EID: 0029658880     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199608000-00012     Document Type: Article

References (44)

1. Shin HS, Bargiello TA, Clark BT, Jackson FR, Young MW. An unusual coding sequence from a Drosophila clock gene is conserved in vertebrates. Nature 1985; 317: 445-8.
2. Konopka RJ. Genetics of biological rhythms in Drosophila. Annu Rev Genet 1987; 21: 277-86.
3. Haus E, Halberg F, Scheving LE, et al. Increased tolerance of leukemic mice to arabinosyl cytosine given on schedule adjusted to circadian system. Science 1972; 177: 80-1.
4. Lévi F, Boughattas N, Blazsek I. Comparative murine chronotoxicity of anticancer agents and related mechanisms. Annu Rev Chronopharmacol 1988; 4: 283-331.
5. Lévi F, Hrushesky W, Blomquist J, et al. Reduction of cis-diamine dichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. Cancer Res 1982; 42: 50-5.
6. Sothern RB, Lévi F, Haus E, Halberg F, Hrushesky W. Control of a murin plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. J Natl Cancer Inst 1989; 81: 135-45.
7. Martineau-Pivoteau N, Lévi F, Cussac C, et al. Circadian rhythm in toxic effect of cystemustine in mice and its relationship with alkyltransferase activity In: 9th NCI EORTC Symp on New Drugs in Cancer Therapy. Amsterdam, The Netherlands, 12-15 March 1996: abstr 406.
8. 6-methylguanine-DNA methyltransferase in mammalian cells Cancer Res 1992; 52: 1804-9.
9. Lemoine A, Lucas C, Ings RMJ. Metabolism of the nirosoureas. Xenobiotica 1991; 21: 775-91.
10. Demple B, Karran P. Death of an enzyme: suicide repair of DNA. Trends Biol Sci 1983; 8: 137-9.
11. Pegg AE. Alkylation and subsequent repair of DNA after exposure to dimethylnitrosamine and related carcinogens. Rev Biochem Toxicol 1983; 5: 93-133.
12. 6-methylguanine-DNA methyltrasferase in cell survival, mutagenesis and carcinogenesis. Mutat Res 1985; 145: 1-16.
13. Lindahl T, Sedwick B, Seriguchi M, Nakabeppu Y. Regulation and expression of adaptative response to alkylating agents. Annu Rev Biochem 1988; 57: 133-57.
14. Demple B. Self-methylation by suicide DNA repair enzymes. In: Paik WM, Kim S, eds. Protein methylation. Boca Raton, FL: CRC Press 1990: 285-304.
15. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 1990; 50: 6119-29.
16. 6-alkylguanine alkyltransferase (AT) in cancer chemotherapy. Cancer Treat Rev 1988; 15: 279-92.
17. 6-methylguanine-DNA methyltransferase and chloroethyl-nitrosourea resistance of human brain tumors. Jpn Clin Oncol 1992; 22: 143-9.
18. 6-alkylguanine. FASEB J 1992; 6: 2302-10.
19. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA contents in human, rat and mouse tissues. Carcinogenesis 1986; 7: 745-9.
20. 6-methylguanine acceptor protein in the tissues of different classes of vertebrates and invertebrates. Comp Biochem Physiol 1986; 85: 125-30.
21. 6-alkylguanine-DNA alkyltransferase. Pharmacol Ther 1987; 34: 167-79.
22. 6-methylguanine in rat pulmonary cells. Carcinogenesis 1988; 9: 2053-8.
23. Day III RS, Ziolkowski CHJ, Scuderio DA, et al. Defective repair of alkylated DNA by human tumor and SV-40 transformed human cells strains. Nature 1980; 288: 18-25.
24. 6-methylguanine in DNA by demethylation is lacking in Mer human tumor cell strains., Carcinogenesis 1983; 4: 199-205.
25. Scuderio AD, Meyer SA, Clatterbuck BE, Mattern MR, Ziolkowski CHJ, Day III RS. Relationship of DNA repair phenotypes of human fibroblast and tumor strains to killing by N-methyl-N′-nitro-N-nitrosoguanidine Cancer Res 1984; 44: 961-9.
26. 6-methylguanine-DNA-methyltransferase proficient (Mer[+]) and deficient (Mer[-]) cell lines. Cancer Res 1986; 46: 2892-7.
27. Karran P, Bignami M. Self destruction and tolerance of mammalian cells to alkylation damage. Nucleic Acids Res 1992; 220: 2933-40.
28. Zlotogorski C, Erickson LC. Pretreatment of human colon tumor with DNA methylating agents inhibits their activity to repair chloroethyl monoadducts. Carcinogenesis 1984; 5: 83-7.
29. Harris B, Song R, Soong S, Diasio RB. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels: evidence for circadian variation of plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continous infusion. Cancer Res 1990; 50: 197-201.
30. El Kouni M, Naquib F. Circadian rhythm of hepatic pyrimidine metabolizing enzymes and plasma uridine concentration in mice In: Proc 5th Int Conf on Chronopharmacol, Amelia Island, EL, July 12-16 1992: abstr IV-2.
31. Zhang R, Lu Z, Liu T, Soong SJ, Diasio RB, Relationship between circadian-dependent toxicity of fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy. Cancer Res 1993; 53: 2816-22.
32. 6-alkylguanine-DNA alkyltransferase mRNA and activity in mouse tissues. Carcinogenesis 1993; 14: 679-83.
33. Cussac C, Inhibition de l'alkyltransférase impliquée dans les phénomènes de résistance aux chloroéthyl-nitrosourées. Application à la chimiothérapie anticancéreuse. Thèse Doctorat ès Sciences en Pharmacocinétique et Pharmacologie Expérimentales. Université d'Auvergne-Clermont-Ferrand, France 1994.
34. 6-methylguanine residues in DNA. Nature 1979; 280: 76-7.
35. 6-methylguanine by mammalian cell extracts in alkylated DNA and poly(dG-m5dC)·(poly dG-m5dC) in B and Z forms. Carcinogenesis 1985; 6: 805-7.
36. Nelson W, Tong Y, Lee JK, Halberg KF. Methods for cosinor rhythmometry. Chronobiologica 1979; 6: 305-23.
37. Lown JW, Laughin LW, Chang YM. Mechanism of action of 2-haloethylnitrosoureas on DNA and its reaction to their antileukemic properties. Biorgan Chem 1978; 7: 97-110.
38. Godenèche D, Rapp M, Thierry A, et al. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells. Cancer Res 1990, 50: 5898-903.
39. 6-benzylguanine on the sensitivity of human xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. Cancer Res 1992; 52: 1171-5.
40. Potter VR, Bariln EF, Watanabe M, Whittle ED. Systematic oscillations in metabolic functions in liver from rats adapted to controlled feeding schedules. Fedn Proc 1968; 27: 1238-45.
41. Nelson W, Scheving L, Halberg E Circadian rhythms in mice fed a single daily meal at different stages of lighting regimen. J Nutr 1975; 105: 171-84.
42. Daher G, Zhang R, Soon SJ, Diasio R. Circadian variation of fluoropyrimidine catabolic enzymes in rat liver: possible relevance to 5-fluorodeoxyuridine chemotherapy. Drug Metab Disp 1991; 19: 285-7.
43. Malmary-Nebot M, Labat C, Casanovas A, Oustrin J. Aspect chronobiologique de l'action du méthotrexate sur la dihydrofolate réductase. Ann Pharm Fr 1985; 43: 337-43.
44. Bélanger PM, Desgagné M, Bruguerolle B. Circadian periodicity in the glutathione concentration of rat liver. Annu Rev Chronopharmacol 1989; 5: 215-8.